Zurich Cantonal Bank’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
163,084
+12,014
+8% +$790K 0.02% 488
2026
Q1
$10.8M Buy
+151,070
New +$11.9M 0.02% 478
2025
Q4
Sell
-116,174
Closed -$9.05M 2939
2025
Q3
$8.72M Buy
116,174
+8,252
+8% +$615K 0.02% 488
2025
Q2
$7.99M Sell
107,922
-65,439
-38% -$4.56M 0.02% 499
2025
Q1
$14M Buy
173,361
+6,271
+4% +$539K 0.04% 383
2024
Q4
$13.1M Buy
167,090
+10,386
+7% +$883K 0.04% 379
2024
Q3
$14.7M Buy
156,704
+2,366
+2% +$199K 0.04% 350
2024
Q2
$12M Buy
154,338
+4,579
+3% +$373K 0.04% 372
2024
Q1
$13.6M Buy
149,759
+1,257
+0.8% +$105K 0.05% 335
2023
Q4
$11.5M Sell
148,502
-384
-0.3% -$26.9K 0.04% 353
2023
Q3
$10.1M Buy
148,886
+16,292
+12% +$1.19M 0.04% 335
2023
Q2
$10.8M Buy
132,594
+6,704
+5% +$535K 0.05% 332
2023
Q1
$10.3M Buy
+125,890
New +$8.99M 0.05% 329

Other funds holding GEHC

Zurich Cantonal Bank's GEHC Position: Q2 2026 in Review

Zurich Cantonal Bank increased its GE HealthCare (GEHC) stake by 8% in Q2 2026, buying an estimated $790K and bringing the position to 163,084 shares worth $10.4M. The position accounts for 0.02% of the portfolio, ranked #488.

Zurich Cantonal Bank first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $14.7M in Q3 2024. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Zurich Cantonal Bank held 163,084 shares of GE HealthCare worth $10.4M as of Q2 2026.
  • Zurich Cantonal Bank bought 12,014 GE HealthCare shares in Q2 2026, an estimated $790K.
  • GE HealthCare made up 0.02% of Zurich Cantonal Bank's portfolio in Q2 2026, its #488 holding.
  • Zurich Cantonal Bank first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Zurich Cantonal Bank's GE HealthCare position peaked at $14.7M in Q3 2024.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.